Results 81 to 90 of about 6,621,562 (305)

Single Questions for the Screening of Anxiety and Depression in Hemodialysis

open access: yesCanadian Journal of Kidney Health and Disease, 2019
Background: Depression and anxiety are common and underrecognized in end-stage renal disease (ESRD), are associated with poor outcomes and reduced health-related quality of life, and are potentially treatable. Simple, accurate screening tools are needed.
David Collister   +7 more
doaj   +1 more source

Evaluating Scientific Impact [PDF]

open access: yesEnvironmental Health Perspectives, 2000
B A, Van Houten   +3 more
openaire   +2 more sources

The Social and Economic Impacts of FreshWorks: An Examination of Three Northgate Gonzalez Grocery Store Investments [PDF]

open access: yes, 2016
In order to better understand and maximize FreshWorks' impact, TCE commissioned a two-year evaluation of the program's food access, social, and economic outcomes.

core  

The Role of Invasive Procedures in the Treatment of Complicated Gastrointestinal Graft‐Versus‐Host Disease in Pediatric Patients

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Gastrointestinal graft‐versus‐host disease (GI GVHD) following hematopoietic stem cell transplant is typically managed with medical therapy, but surgery and angioembolization may be warranted in selected cases with life‐threatening complications.
Gaia Brunetti   +12 more
wiley   +1 more source

Evaluation Capacity Development through Cluster Evaluation

open access: yesJournal of MultiDisciplinary Evaluation, 2015
Background:  The term “cluster evaluation” was first coined in 1988 by W. K. Kellogg staff in an evaluation of a Foundation-funded initiative; the concept was further developed and practiced by the Kellogg Foundation evaluation consultants and other ...
Khalil Bitar   +3 more
doaj   +1 more source

Two Faces of NOTCH1 in Childhood Lymphoblastic T‐Cell Neoplasia: Prognostic Divergence of Mutational and Structural Aberrations

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT In pediatric patients, T‐cell lymphoblastic lymphoma (T‐LBL) survival exceeds 80%. Relapse remains associated with limited curative options. Frontline treatment is largely extrapolated from T‐cell acute lymphoblastic leukemia (T‐ALL) treatment, reflecting the ongoing debate, whether both entities represent distinct diseases or variants within ...
Marie C. Heider   +4 more
wiley   +1 more source

Investing in Impact: Media Summits Reveal Pressing Needs, Tools for Evaluating Public Interest Media [PDF]

open access: yes, 2010
Outlines the case for assessing the impact of public interest media projects, impact evaluation needs, and five new assessment tools, including a unified social media dashboard, model formats and processes to communicate outcomes, and common survey ...

core  

Blinatumomab Utilization in Pediatric B‐Cell Acute Lymphoblastic Leukemia: Experience From the Mountain West

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Blinatumomab is a bispecific T‐cell engager approved for the treatment of pediatric B‐cell acute lymphoblastic leukemia (B‐ALL). Outpatient home infusion reduces hospitalization burden and optimizes resource utilization, but is logistically challenging.
Angela Parra del Riego   +10 more
wiley   +1 more source

Impact Evaluation of Interoperability Decision Variables on P2P Collaboration Performances [PDF]

open access: yes, 2012
This article deals with the impact evaluation of interoperability decision variables on performance indicators of business processes. The case of partner companies is studied to show the interest of an Interoperability Service Utility (ISU) on business ...
Archimède, Bernard   +2 more
core   +2 more sources

Ethnic Differences in the Association Between SOD2 rs4880 and Hepatotoxicity in Pediatric Acute Lymphoblastic Leukemia: A Report From the REDIAL Consortium

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Treatment‐associated hepatotoxicity (TAH) is a common complication of pediatric acute lymphoblastic leukemia (ALL) treatment, but genetic risk factors remain poorly understood. We evaluated the SOD2 rs4880 variant in 544 children with ALL at Texas Children's Hospital. After adjusting for demographic and clinical covariates, the rs4880 C allele
Emily J. Mason   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy